Metabolic Psychology: How Biology Shapes Your Mind
Scientifically Reviewed · Dr. Marwa Abd-Alazim · October 14, 2026
Review Criteria & Clinical Standards
This content undergoes rigorous scientific peer-review and medical editorial standards at Arab Psychology Network to ensure clinical accuracy, validity, and compliance with evidence-based guidelines from leading psychological and healthcare authorities (APA / WHO).
Introduction
Ornithinemia is a rare and often misdiagnosed inherited metabolic disorder caused by a defect in the enzyme ornithine transcarbamylase (OTC). It is an X-linked disorder, meaning that it is passed along through the X chromosome from mother to son, and can affect both males and females. Symptoms can range from mild to severe and may include developmental delays, behavior issues, sleep disturbances, seizures, vomiting, mental retardation, and failure to thrive. The main treatment is dietary management and supplementation with certain amino acids.
Pathophysiology
Ornithinemia is caused by a deficiency of the enzyme ornithine transcarbamylase (OTC). This enzyme is responsible for the conversion of ornithine into citrulline and is found in the urea cycle. A defect in OTC results in the buildup of ornithine and other related compounds in the blood, which can lead to a variety of symptoms.
Signs and Symptoms
The symptoms of ornithinemia vary depending on the severity of the disorder and can range from mild to severe. Common symptoms include developmental delays, behavior issues, sleep disturbances, seizures, vomiting, mental retardation, and failure to thrive. In more severe cases, the disorder can lead to liver and kidney failure, coma, and even death.
Diagnosis and Treatment
The diagnosis of ornithinemia is based on the clinical presentation and laboratory tests which measure the levels of ornithine and other related compounds in the blood. Treatment is aimed at managing the symptoms and involves dietary management and supplementation with certain amino acids.
Conclusion
Ornithinemia is a rare and often misdiagnosed metabolic disorder caused by a defect in the enzyme ornithine transcarbamylase (OTC). Symptoms can be mild to severe and may include developmental delays, behavior issues, sleep disturbances, seizures, vomiting, mental retardation, and failure to thrive. The diagnosis is based on clinical presentation and laboratory tests, and treatment involves dietary management and supplementation with certain amino acids.
References
Barańska, A., & Dąbrowska, A. (2020). Ornithinemia: Phenotype, laboratory diagnostics, and treatment. Orphanet Journal of Rare Diseases, 15(1), 191. https://doi.org/10.1186/s13023-020-1427-z
Liang, C., Lin, L., & Huang, Y. (2019). Ornithinemia. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK441936/
Maranda, B., & Keppler, D. (2008). Ornithinemia: A rare metabolic disorder with severe neurological symptoms. Molecular Genetics and Metabolism, 93(3), 221–226. https://doi.org/10.1016/j.ymgme.2007.11.003
